(Q34207037)

English

Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

M A Konerman

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

S Yapali

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A S Lok

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

28 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

863-879

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Sofosbuvir for previously untreated chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Management of hepatocellular carcinoma: An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Role of simple biomarkers in predicting fibrosis progression in HCV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167918

5 July 2018

Fibrosis progression in initially mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Progression of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Rebiopsy in patients with untreated hepatitis C: a useful procedure

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Disease progression and the risk factor analysis for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12921

21 January 2018

The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25164152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The increasing burden of mortality from viral hepatitis in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/25164152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/APT.12921

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34207037&oldid=1961669301"